down arrow

Wanbury

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE107F01022
  • NSEID: WANBURY
  • BSEID: 524212
INR
244.45
9.45 (4.02%)
BSENSE

Apr 11, 12:48 PM

BSE+NSE Vol: 52.99 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

238.00245.00

52 Week

132.55325.00
Valuation
Technical
Day's Volume

CASH

52.99 k (-49.85%) Volume

Shareholding (Sep 2024)

FII

1.02%

Held by 4 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

39.77%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

High Debt company with Weak Long Term Fundamental Strength

  • Poor long term growth as Net Sales has grown by an annual rate of 7.05% and Operating profit at 11.65% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at 0 times
2

With a fall in Net Sales of -17.21%, the company declared Very Negative results in Dec 24

3

Stock is technically in a Mildly Bearish range

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 787 Cr (Micro Cap)

stock-summary
P/E

42.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

4.36

stock-summary
Return on Equity

71.23%

stock-summary
Price to Book

19.87

Revenue and Profits (1 Year):
Net Sales:
133 Cr
(Quarterly Results - Dec 2024)
Net Profit:
1 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-2.45%
0%
-2.45%
1 Year
53.65%
0%
53.65%
2 Years
552.21%
0%
552.21%
3 Years
183.42%
0%
183.42%
4 Years
142.15%
0%
142.15%
5 Years
1034.34%
0%
1034.34%

Latest dividend: 1 per share ex-dividend date: Jul-29-2010

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
7.05%
EBIT Growth (5y)
11.65%
EBIT to Interest (avg)
0.86
Debt to EBITDA (avg)
5.36
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
7.52
Tax Ratio
1.10%
Dividend Payout Ratio
0
Pledged Shares
76.74%
Institutional Holding
0.84%
ROCE (avg)
29.21%
ROE (avg)
17.81%
Valuation key factors
Factor
Value
P/E Ratio
42
Industry P/E
33
Price to Book Value
19.87
EV to EBIT
18.83
EV to EBITDA
14.88
EV to Capital Employed
4.52
EV to Sales
1.66
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
27.48%
ROE (Latest)
71.23%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

76.7355

Mutual Funds

Held by 2 Schemes (0.0%)

FIIs

Held by 4 FIIs (1.02%)

Promoter with highest holding

Expert Chemicals (india) Pvt Ltd (30.53%)

Highest Public shareholder

Authum Investment And Infrastructure Limited (2.34%)

Individual Investors Holdings

40.66%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -17.21% vs 22.94% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -84.79% vs 671.15% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "133.45",
          "val2": "161.19",
          "chgp": "-17.21%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13.94",
          "val2": "20.00",
          "chgp": "-30.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "10.17",
          "val2": "10.15",
          "chgp": "0.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.22",
          "val2": "8.02",
          "chgp": "-84.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.45%",
          "val2": "12.41%",
          "chgp": "-1.96%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 0.53% vs 20.70% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -24.81% vs 248.22% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "292.30",
          "val2": "290.75",
          "chgp": "0.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "30.98",
          "val2": "30.70",
          "chgp": "0.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "17.74",
          "val2": "13.46",
          "chgp": "31.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "9.06",
          "val2": "12.05",
          "chgp": "-24.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.60%",
          "val2": "10.56%",
          "chgp": "0.04%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -2.41% vs 18.98% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -53.94% vs 295.62% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "425.75",
          "val2": "436.25",
          "chgp": "-2.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "44.92",
          "val2": "51.85",
          "chgp": "-13.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "27.91",
          "val2": "21.72",
          "chgp": "28.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "10.28",
          "val2": "22.32",
          "chgp": "-53.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.55%",
          "val2": "11.89%",
          "chgp": "-1.34%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 15.21% vs -2.26% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 638.08% vs -112.77% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "575.65",
          "val2": "499.65",
          "chgp": "15.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "70.00",
          "val2": "23.17",
          "chgp": "202.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "29.18",
          "val2": "21.39",
          "chgp": "36.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "25.56",
          "val2": "-0.59",
          "chgp": "4,432.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "55.96",
          "val2": "-10.40",
          "chgp": "638.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.16%",
          "val2": "4.64%",
          "chgp": "7.52%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
133.45
161.19
-17.21%
Operating Profit (PBDIT) excl Other Income
13.94
20.00
-30.30%
Interest
10.17
10.15
0.20%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1.22
8.02
-84.79%
Operating Profit Margin (Excl OI)
10.45%
12.41%
-1.96%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -17.21% vs 22.94% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -84.79% vs 671.15% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
292.30
290.75
0.53%
Operating Profit (PBDIT) excl Other Income
30.98
30.70
0.91%
Interest
17.74
13.46
31.80%
Exceptional Items
0.00
0.00
Consolidate Net Profit
9.06
12.05
-24.81%
Operating Profit Margin (Excl OI)
10.60%
10.56%
0.04%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 0.53% vs 20.70% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -24.81% vs 248.22% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
425.75
436.25
-2.41%
Operating Profit (PBDIT) excl Other Income
44.92
51.85
-13.37%
Interest
27.91
21.72
28.50%
Exceptional Items
0.00
0.00
Consolidate Net Profit
10.28
22.32
-53.94%
Operating Profit Margin (Excl OI)
10.55%
11.89%
-1.34%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -2.41% vs 18.98% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -53.94% vs 295.62% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
575.65
499.65
15.21%
Operating Profit (PBDIT) excl Other Income
70.00
23.17
202.11%
Interest
29.18
21.39
36.42%
Exceptional Items
25.56
-0.59
4,432.20%
Consolidate Net Profit
55.96
-10.40
638.08%
Operating Profit Margin (Excl OI)
12.16%
4.64%
7.52%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 15.21% vs -2.26% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 638.08% vs -112.77% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Wanbury Ltd stock-summary
stock-summary
Wanbury Ltd
Micro Cap
Pharmaceuticals & Drugs
Wanbury Ltd (Formerly known Pearl Organics Limited) was incorporated in August, 1988. The Company is engaged in the business of pharmaceutical and related activities, including research. The company has established its first plant in the year 1992 in Tarapur for manufacturing APIs. In 1995, the Company acquired plant of Brij Chemicals Pvt Ltd at Patalganga. In 1996, it entered into a strategic alliance with Wyckoff Chemicals to manufacture its API in US.
Company Coordinates stock-summary
Company Details
BSEL Tech Park B-Wing 10th Flr, Sector 30 A Opp Vashi Rly Stat Navi Mumbai Maharashtra : 400703
stock-summary
Tel: 91-22-67942222
stock-summary
http://www.wanbury.com
stock-summary
shares@wanbury.com
Registrar Details
Sharex Dynamic (India) Pvt Ltd , Unit -1, Luthra Ind. Premises , Safed Pool, Andheri-Kurla Road, Andheri (E), Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."